vimarsana.com
Home
Live Updates
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug : comparemela.com
Biomica Successfully Completes Phase I Trial Enrollment for Microbiome-Based Immuno-Oncology Drug
The final patient completes Phase I trial enrollment, evaluating safety and tolerability for Biomica's microbiome-based immuno-oncology drug, BMC128
REHOVOT, Israel, Jan. 17, 2024 /PRNewswire/ --...
Related Keywords
Israel ,
Rehovot ,
Hamerkaz ,
Lavie Bio ,
Bristol Myers Squibb Opdivo ,
Elran Haber ,
Rachel Pomerantz Gerber ,
Evogene Ltd ,
Biomica Ltd ,
Rambam Health Care Campus ,
Prnewswire Biomica Ltd ,
Davidoff Center ,
Nasdaq ,
Myers Squibb ,
Live Bacterial Product ,
Big Data ,
Artificial Intelligence ,
Looking Statements ,
Investor Relations ,
Markets ,
comparemela.com © 2020. All Rights Reserved.